XML 44 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment reporting (Tables)
9 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes
The following is a summary of segment net revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income before income taxes:
Three months ended September 30,Nine months ended September 30,
 2022202120222021
Segment revenues:  
U.S. dialysis  
Dialysis patient service revenues:  
External sources$2,674,240 $2,669,823 $7,858,939 $7,874,759 
Intersegment revenues22,957 22,007 64,526 70,196 
U.S. dialysis patient service revenues2,697,197 2,691,830 7,923,465 7,944,955 
Other revenues:
External sources6,056 6,119 18,134 19,080 
Intersegment revenues— 97 (10)228 
Total U.S. dialysis revenues2,703,253 2,698,046 7,941,589 7,964,263 
Other—Ancillary services
Dialysis patient service revenues172,254 168,117 513,935 495,725 
Other external sources96,144 94,260 301,998 285,266 
Intersegment revenues— — — 4,294 
Total ancillary services revenues268,398 262,377 815,933 785,285 
Total net segment revenues2,971,651 2,960,423 8,757,522 8,749,548 
Elimination of intersegment revenues(22,957)(22,104)(64,516)(74,718)
Consolidated revenues$2,948,694 $2,938,319 $8,693,006 $8,674,830 
Segment operating margin (loss):  
U.S. dialysis$351,474 $509,939 $1,230,715 $1,523,625 
Other—Ancillary services(15,271)(6,909)(56,689)(36,577)
Total segment operating margin336,203 503,030 1,174,026 1,487,048 
Reconciliation of segment operating income to
 consolidated income before income taxes:
  
Corporate administrative support(24,417)(28,153)(91,217)(79,093)
Consolidated operating income311,787 474,877 1,082,810 1,407,955 
Debt expense(99,680)(72,829)(256,057)(213,167)
Other (loss) income, net(4,898)(7,590)(7,968)8,766 
Consolidated income before income taxes$207,209 $394,458 $818,785 $1,203,554 
Summary of Depreciation and Amortization Expense by Reportable Segment
Depreciation and amortization expense by reportable segment was as follows:
Three months ended September 30,Nine months ended September 30,
 2022202120222021
U.S. dialysis$184,688 $161,252 $507,320 $477,054 
Other—Ancillary services9,726 9,210 31,214 28,798 
 $194,414 $170,462 $538,534 $505,852 
Summary of Expenditures for Property and Equipment by Reportable Segment Expenditures for property and equipment by reportable segment were as follows:
Nine months ended September 30,
 20222021
U.S. dialysis$363,046 $415,994 
Other—Ancillary services46,345 35,915 
 $409,391 $451,909 
Summary of Assets by Reportable Segment
A summary of assets by reportable segment were as follows:
September 30, 2022December 31, 2021
U.S. dialysis$15,223,532 $15,375,000 
Other—Ancillary services1,738,267 1,746,488 
Consolidated assets$16,961,799 $17,121,488